The clearance enables Alphyn to initiate global phase 2b clinical trials, which are anticipated to begin in the first quarter of 2025.

Tips cover biologic agents and hepatitis B, 5-FU plus calcipotriene for AK, a triple treatment package for post-acne postinflammatory hyperpigmentation, and more.

Neal Bhatia, MD, highlighted updates in the management of actinic keratosis, emphasizing strategies to reduce skin cancer risk and improve patient outcomes.

Cheri Frey, MD, explored novel active ingredients, advancements in skin care formulations at the Midwinter Clinical Derm Conference.

The sudden appearance of "a black nail" can frighten a patient and should be investigated. Nail expert Boni Elewski, MD, shares 3 cases and the outcomes.

Susan C Taylor, MD, is internationally recognized for her expertise in dermatologic conditions in skin of color and spoke about avoiding photodamage at the Midwinter Clinical Derm Conference.

Established therapies for these common disorders don't always lead to optimal results; experts offer new evidence-based options that may help.

Systemic therapy for nail disorders, including biologics and JAK inhibitors, is gaining favor; learn more about early diagnosis and aggressive treatment from an expert.

Theodore Rosen, MD, underscored the critical need for responsible antibiotic use in dermatology to combat the accelerating crisis of drug-resistant infections.

Insights into managing molluscum contagiosum, HPV-related warts, and other infections took center stage at the Midwinter Clinical Hawaii Derm Conference.